Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein D-like (HNRNPDL)

Target
HNRNPDL
Molecular classification
RNA-binding protein, Heterogeneous nuclear ribonucleoprotein (hnRNP) family, Contains RNA recognition motif (RRM) domains, Functional amyloid-forming protein
01

Overview

Heterogeneous nuclear ribonucleoprotein D-like (HNRNPDL) is an RNA-binding protein belonging to the hnRNP family, which is ubiquitously expressed and involved in the regulation of alternative pre-mRNA splicing, mRNA stability, transport, and the assembly of ribonucleoprotein granules. HNRNPDL contains two RNA recognition motif (RRM) domains and exists as several naturally occurring isoforms due to alternative splicing, with hnRNPDL-2 being predominant in human tissues. The protein localizes to the nucleus and is involved in the formation of functional amyloid fibrils, which are non-toxic and capable of binding nucleic acids. Missense mutations in HNRNPDL are associated with limb-girdle muscular dystrophy D3 (LGMD D3), a rare hereditary disease characterized by progressive proximal muscle weakness. While amyloid formation by certain proteins is often pathological, hnRNPDL-2's amyloid structure is considered functional and may be regulated by alternative splicing of specific exons. HNRNPDL is not currently a direct therapeutic target, and no interacting drugs or clinical biomarkers are established.

Other names
hnRNP D-likehnRNP DLJKTBPJKTBP2laAUF1AU-rich element RNA-binding factorJKT41-binding proteinprotein laAUF1LGMDD3LGMD1Glimb-girdle muscular dystrophy 1G (autosomal dominant)
02

Biological functions

Alternative pre-mRNA splicingRegulation of mRNA stabilitymRNA transportAssembly of ribonucleoprotein granulesBinds single-stranded nucleic acids (RNA, ssDNA)Possible roles in liquid–liquid phase separation and nuclear compartmentalization
03

Disease associations

Limb-girdle muscular dystrophy D3 (LGMD D3) / LGMDD3Implicated in neurodegenerative diseases (extrapolated from hnRNP family)Cancer (extrapolated from hnRNP family)

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein D-like (HNRNPDL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein D-like (HNRNPDL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call